| Jacqueline Elaine Bullard, OD | |
|
22 N Jackson St, Belleville, IL 62220-1425 | |
| (618) 233-1270 | |
| (618) 233-5939 |
| Full Name | Jacqueline Elaine Bullard |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 7 Years |
| Location | 22 N Jackson St, Belleville, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962927764 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 064011144 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovative Eye Care Solutions Ltd | 9234186628 | 2 |
News Archive
Rarely will physicians use the word "miraculous" when discussing patient recoveries. But that's the very phrase orthopaedic physicians and scientists are using in upstate New York to describe their emerging stem cell research that could have a profound impact on the treatment of bone injuries. Results from preliminary work being released today, patients confined to wheelchairs were able to walk or live independently again because their broken bones finally healed.
Cell therapies for a range of serious conditions, including heart attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute that yielded a newly patented method of converting human skin cells into engines of wound healing and tissue regeneration.
Thousands of Americans suffering from the chronic inflammatory bowel condition known as Crohn's disease are leading longer, healthier lives due to innovative new surgeries, according to experts at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Text message reminders to parents about flu vaccinations may help boost the number of children vaccinated, according to researchers at Columbia University Medical Center and NewYork-Presbyterian Hospital. Full study findings are reported in the April 25 issue of the Journal of the American Medical Association.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
› Verified 7 days ago
| Provider Name | Innovative Eye Care Solutions Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1811088404 PECOS PAC ID: 9234186628 Enrollment ID: O20050407000552 |
News Archive
Rarely will physicians use the word "miraculous" when discussing patient recoveries. But that's the very phrase orthopaedic physicians and scientists are using in upstate New York to describe their emerging stem cell research that could have a profound impact on the treatment of bone injuries. Results from preliminary work being released today, patients confined to wheelchairs were able to walk or live independently again because their broken bones finally healed.
Cell therapies for a range of serious conditions, including heart attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute that yielded a newly patented method of converting human skin cells into engines of wound healing and tissue regeneration.
Thousands of Americans suffering from the chronic inflammatory bowel condition known as Crohn's disease are leading longer, healthier lives due to innovative new surgeries, according to experts at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Text message reminders to parents about flu vaccinations may help boost the number of children vaccinated, according to researchers at Columbia University Medical Center and NewYork-Presbyterian Hospital. Full study findings are reported in the April 25 issue of the Journal of the American Medical Association.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Elaine Bullard, OD 22 N Jackson St, Belleville, IL 62220-1425 Ph: (618) 233-1270 | Jacqueline Elaine Bullard, OD 22 N Jackson St, Belleville, IL 62220-1425 Ph: (618) 233-1270 |
News Archive
Rarely will physicians use the word "miraculous" when discussing patient recoveries. But that's the very phrase orthopaedic physicians and scientists are using in upstate New York to describe their emerging stem cell research that could have a profound impact on the treatment of bone injuries. Results from preliminary work being released today, patients confined to wheelchairs were able to walk or live independently again because their broken bones finally healed.
Cell therapies for a range of serious conditions, including heart attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute that yielded a newly patented method of converting human skin cells into engines of wound healing and tissue regeneration.
Thousands of Americans suffering from the chronic inflammatory bowel condition known as Crohn's disease are leading longer, healthier lives due to innovative new surgeries, according to experts at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Text message reminders to parents about flu vaccinations may help boost the number of children vaccinated, according to researchers at Columbia University Medical Center and NewYork-Presbyterian Hospital. Full study findings are reported in the April 25 issue of the Journal of the American Medical Association.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
› Verified 7 days ago
Clarkson Optometry Illinois Pc Optometrist Medicare: Medicare Enrolled Practice Location: 2525 Green Mount Crossing Dr., Suite 290, Belleville, IL 62221 Phone: 636-200-4393 Fax: 618-233-7290 | |
Vep Il Optometric Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5650 Belleville Crossing St, Belleville, IL 62226 Phone: 618-234-2020 | |
David B. Hartig O.d. Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 120 Carlyle Plaza Dr, Belleville, IL 62221 Phone: 618-236-2266 Fax: 618-236-2288 | |
Quantum Vision Centers Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4900 W Main St, Belleville, IL 62226 Phone: 618-235-2400 Fax: 618-235-0900 | |
Avc Optometry Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3540 N Belt W Ste C, Belleville, IL 62226 Phone: 618-235-4433 Fax: 618-235-7483 | |
Drs. Becherer, Becherer & Associates, Ltd Optometrist Medicare: Medicare Enrolled Practice Location: 1 Park Place Professional Ctr., Belleville, IL 62226 Phone: 618-233-3040 Fax: 618-233-3739 | |
Dr. Thomas Errol Kraemer, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3540 N Belt W, Ste C, Belleville, IL 62226 Phone: 618-235-4433 Fax: 618-235-7483 |